[go: up one dir, main page]

AU4571099A - Matrix metalloproteinase proenzyme activator - Google Patents

Matrix metalloproteinase proenzyme activator

Info

Publication number
AU4571099A
AU4571099A AU45710/99A AU4571099A AU4571099A AU 4571099 A AU4571099 A AU 4571099A AU 45710/99 A AU45710/99 A AU 45710/99A AU 4571099 A AU4571099 A AU 4571099A AU 4571099 A AU4571099 A AU 4571099A
Authority
AU
Australia
Prior art keywords
matrix metalloproteinase
proenzyme activator
metalloproteinase proenzyme
activator
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45710/99A
Inventor
Christine A. Towle
Benjamin V Treadwell
Marianne Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU4571099A publication Critical patent/AU4571099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU45710/99A 1998-06-16 1999-06-16 Matrix metalloproteinase proenzyme activator Abandoned AU4571099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8950198P 1998-06-16 1998-06-16
US60089501 1998-06-16
PCT/US1999/013572 WO1999065519A1 (en) 1998-06-16 1999-06-16 Matrix metalloproteinase proenzyme activator

Publications (1)

Publication Number Publication Date
AU4571099A true AU4571099A (en) 2000-01-05

Family

ID=22217993

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45710/99A Abandoned AU4571099A (en) 1998-06-16 1999-06-16 Matrix metalloproteinase proenzyme activator

Country Status (2)

Country Link
AU (1) AU4571099A (en)
WO (1) WO1999065519A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6262601A (en) * 2000-05-25 2001-12-03 Ben Williger Phospholipase d effectors for therapy and screening
US7041787B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
CN111465408B (en) 2017-12-15 2023-07-04 泰伦基国际有限公司 Method and medicine for preventing or treating osteoarthritis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy

Also Published As

Publication number Publication date
WO1999065519A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
AU6041998A (en) Novel prostate-associated kallikrein
AU7127298A (en) Serine protease inhibitors
AU8858398A (en) Matrix metalloproteinase inhibitors
AU4723799A (en) Protease inhibitors
AU3342297A (en) Matrix metalloproteinase inhibitors
AU4170499A (en) Bleaching activator
AU7139598A (en) Protease inhibitors
AU1808999A (en) Fibrinolytic inhibitor for sealant
AU4092799A (en) Protease inhibitors
AU3827897A (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
IL136889A0 (en) Matrix metalloprotease inhibitors
AU4571099A (en) Matrix metalloproteinase proenzyme activator
AU9110298A (en) Protease inhibitors
AU1393900A (en) Morpholino-ethoxybenzofuran protease inhibitors
AU2001241498A1 (en) Matrix metalloproteinase inhibitors and uses thereof
AU1906999A (en) Mammalian matrix-type metalloprotease
AU6053698A (en) Plasminogen activator as an anti-inflammatory agent
AU4564499A (en) Protease inhibitors
AU2713100A (en) Protease inhibitors
AU9300298A (en) Protease inhibitors
AU9158898A (en) Novel metalloprotease
AU9747098A (en) Aporphinoid matrix metalloproteinase inhibitors
AU7066398A (en) Novel use of matrix metalloproteinase inhibitors
AU7252398A (en) Protease inhibitors
AU7295500A (en) Stromelysin-homologous novel mmp-27 matrix metalloproteinase

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase